Job Openings
Scientist I, Neuroscience Biology
July 18, 2022
COMPANY DESCRIPTION: Building on our founders’ Nobel-prize winning discoveries in RNA interference, Atalanta Therapeutics is developing novel branched siRNA therapeutics to treat severe neurological diseases at the root cause. With two active partnerships with large biopharmaceutical companies plus a robust internal pipeline, Atalanta is poised to make a difference in patients’ lives. Atalanta fosters a […]
Associate Scientist/Senior Associate Scientist – Bioinformatics
April 1, 2022
COMPANY DESCRIPTION: Building on our founders’ Nobel-prize winning discoveries in RNA interference, Atalanta Therapeutics is developing novel branched siRNA therapeutics to treat severe neurological diseases at the root cause. With two active partnerships with large biopharmaceutical companies plus a robust and growing internal pipeline, Atalanta is poised to make a difference in patients’ lives with […]
Data Engineer – Bioinformatics
April 1, 2022
COMPANY DESCRIPTION: Building on our founders’ Nobel-prize winning discoveries in RNA interference, Atalanta Therapeutics is developing novel branched siRNA therapeutics to treat severe neurological diseases at the root cause. With two active partnerships with large biopharmaceutical companies plus a robust and growing internal pipeline, Atalanta is poised to make a difference in patients’ lives with […]
Scientist I/II, In Vivo Pharmacology
January 19, 2022
COMPANY DESCRIPTION Atalanta Therapeutics is a biotechnology company developing novel oligonucleotide therapeutics for the treatment of genetically defined neurodegenerative diseases. Our founders’ groundbreaking discoveries in RNA interference offer a powerful therapeutic approach to halt diseases at their source. Atalanta fosters a culture of integrity, respect, collaboration, opportunity, learning, and fun. We are located in Boston’s […]
Senior Associate Scientist, In Vivo Pharmacology
January 19, 2022
COMPANY DESCRIPTION: Building on our founders’ Nobel-prize winning discoveries in RNA interference, Atalanta Therapeutics is developing novel branched siRNA therapeutics to treat severe neurological diseases at the root cause. With two active partnerships with large biopharmaceutical companies plus a robust and growing internal pipeline, Atalanta is poised to make a difference in patients’ lives. Atalanta […]
Scientist/Senior Scientist, Oligonucleotide Chemistry
December 20, 2021
COMPANY DESCRIPTION: Building on our founders’ Nobel-prize winning discoveries in RNA interference, Atalanta Therapeutics is developing novel branched siRNA therapeutics to treat severe neurological diseases at the root cause. With two active partnerships with large biopharmaceutical companies plus a robust and growing internal pipeline, Atalanta is poised to make a difference in patients’ lives. Atalanta […]
Associate Scientist/Senior Associate Scientist, Oligonucleotide Chemistry
December 20, 2021
COMPANY DESCRIPTION: Building on our founders’ Nobel-prize winning discoveries in RNA interference, Atalanta Therapeutics is developing novel branched siRNA therapeutics to treat severe neurological diseases at the root cause. With two active partnerships with large biopharmaceutical companies plus a robust and growing internal pipeline, Atalanta is poised to make a difference in patients’ lives. Atalanta […]
Scientist II/Senior Scientist, Bioanalytics/DMPK
February 17, 2021
COMPANY DESCRIPTION: Atalanta Therapeutics is a biotechnology company developing novel oligonucleotide therapeutics for the treatment of genetically defined neurodegenerative diseases. Our founders’ groundbreaking discoveries in RNA interference offer a powerful therapeutic approach to halt diseases at their source. Atalanta fosters a culture of integrity, respect, collaboration, opportunity, learning, and fun. We are located in Boston’s […]